Kelly Lawrence W & Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-76,572
Closed -$4.91M 135
2018
Q4
$4.91M Sell
76,572
-57,201
-43% -$4.22M 1.06% 31
2018
Q3
$12M Buy
133,773
+774
+0.6% +$68.4K 1.97% 22
2018
Q2
$10.6M Sell
132,999
-120
-0.1% -$9.96K 1.94% 24
2018
Q1
$11.9M Sell
133,119
-2,500
-2% -$240K 2.25% 22
2017
Q4
$14.2M Sell
135,619
-580
-0.4% -$65.4K 2.6% 17
2017
Q3
$19.9M Sell
136,199
-1,656
-1% -$226K 3.78% 4
2017
Q2
$17.9M Buy
137,855
+410
+0.3% +$50.2K 3.54% 3
2017
Q1
$17.1M Sell
137,445
-234
-0.2% -$28K 3.53% 4
2016
Q4
$15.9M Buy
137,679
+10,765
+8% +$1.2M 3.53% 5
2016
Q3
$13.3M Sell
126,914
-544
-0.4% -$58.9K 2.84% 10
2016
Q2
$12.6M Buy
127,458
+35,435
+39% +$3.67M 2.91% 12
2016
Q1
$9.21M Buy
92,023
+875
+1% +$90.1K 2.31% 20
2015
Q4
$10.9M Sell
91,148
-45,525
-33% -$5.27M 2.47% 20
2015
Q3
$14.8M Sell
136,673
-7,415
-5% -$920K 3.43% 5
2015
Q2
$16.7M Buy
144,088
+975
+0.7% +$111K 3.32% 4
2015
Q1
$16.5M Sell
143,113
-4,045
-3% -$483K 3.56% 6
2014
Q4
$16.5M Sell
147,158
-13,875
-9% -$1.46M 3.43% 3
2014
Q3
$15.3M Sell
161,033
-8,115
-5% -$732K 3.25% 5
2014
Q2
$14.5M Buy
169,148
+8,000
+5% +$608K 3.1% 8
2014
Q1
$11.2M Sell
161,148
-980
-0.6% -$77.6K 2.58% 17
2013
Q4
$13.7M Sell
162,128
-29,930
-16% -$2.37M 3.05% 9
2013
Q3
$14.8M Sell
192,058
-850
-0.4% -$59.6K 3.5% 5
2013
Q2
$11.3M Buy
+192,908
New +$11.6M 2.86% 16

Other funds holding CELG

Kelly Lawrence W & Associates's CELG Position: Q1 2019 in Review

Kelly Lawrence W & Associates sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 76,572 shares — an estimated $4.91M sold.

Kelly Lawrence W & Associates first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $19.9M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Kelly Lawrence W & Associates reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 76,572 Celgene Corp shares in Q1 2019, an estimated $4.91M.
  • Kelly Lawrence W & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Kelly Lawrence W & Associates's Celgene Corp position peaked at $19.9M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2019, filed 15 May 2019.